Back to Search Start Over

Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms race.

Authors :
Ibrahim-Hashim A
Luddy K
Abrahams D
Enriquez-Navas P
Damgaci S
Yao J
Chen T
Bui MM
Gillies RJ
O'Farrelly C
Richards CL
Brown JS
Gatenby RA
Source :
British journal of cancer [Br J Cancer] 2021 Jan; Vol. 124 (2), pp. 455-465. Date of Electronic Publication: 2020 Oct 07.
Publication Year :
2021

Abstract

Background: Cancer progression is governed by evolutionary dynamics in both the tumour population and its host. Since cancers die with the host, each new population of cancer cells must reinvent strategies to overcome the host's heritable defences. In contrast, host species evolve defence strategies over generations if tumour development limits procreation.<br />Methods: We investigate this "evolutionary arms race" through intentional breeding of immunodeficient SCID and immunocompetent Black/6 mice to evolve increased tumour suppression. Over 10 generations, we injected Lewis lung mouse carcinoma cells [LL/2-Luc-M38] and selectively bred the two individuals with the slowest tumour growth at day 11. Their male progeny were hosts in the subsequent round.<br />Results: The evolved SCID mice suppressed tumour growth through biomechanical restriction from increased mesenchymal proliferation, and the evolved Black/6 mice suppressed tumour growth by increasing immune-mediated killing of cancer cells. However, transcriptomic changes of multicellular tissue organisation and function genes allowed LL/2-Luc-M38 cells to adapt through increased matrix remodelling in SCID mice, and reduced angiogenesis, increased energy utilisation and accelerated proliferation in Black/6 mice.<br />Conclusion: Host species can rapidly evolve both immunologic and non-immunologic tumour defences. However, cancer cell plasticity allows effective phenotypic and population-based counter strategies.

Details

Language :
English
ISSN :
1532-1827
Volume :
124
Issue :
2
Database :
MEDLINE
Journal :
British journal of cancer
Publication Type :
Academic Journal
Accession number :
33024265
Full Text :
https://doi.org/10.1038/s41416-020-01110-1